Research study of an investigational medication for Sleep Maintenance Insomnia

Study Description

A Randomized, Double-blind, Placebo-controlled Subjective Study to Assess the Efficacy of XXX in Patients with Primary Insomnia Characterized by Difficulty Maintaining Sleep

Length of study: 5 weeks

Number of office visits: 5 for most subjects

At no cost, qualified participants receive study medication and study related services. In addition there is compensation up to $450.00 for participation in the study.

Study inclusion/exclusion criteria

This study is only available to persons who:

• Can fluently read and speak English.
• Are 18 to 65 years old.
• Are without serious health problems.
• Are not addicted to drugs or alcohol.
• Are not currently taking sedating medication or supplements.
   

[Home] [For Patients] [Studies] [FAQ] [Sponsor Overview] [Contact Us]